These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 19822495

  • 1. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS, Song PL, Sun B, Jiang HC, Liu TF.
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J, Wang B.
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp.
    Han B, Zhou G, Zhang Q, Zhang J, Wang X, Tang W, Kakudo K.
    J Exp Ther Oncol; 2004 Dec; 4(4):335-42. PubMed ID: 15844663
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 8. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May 08; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
    Wang Y, An R, Dong X, Pan S, Duan G, Sun X.
    Urol Int; 2009 May 08; 82(2):214-21. PubMed ID: 19322013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
    Liu F, Zhang Y, Zhang XY, Chen HL.
    J Cancer Res Clin Oncol; 2002 Apr 08; 128(4):189-96. PubMed ID: 11935309
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S, Knox SJ.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):197-203. PubMed ID: 15337556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
    Binet F, Girard D.
    J Leukoc Biol; 2008 Dec 01; 84(6):1613-22. PubMed ID: 18728151
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
    Han YH, Kim SZ, Kim SH, Park WH.
    Cancer Lett; 2008 Oct 18; 270(1):40-55. PubMed ID: 18539383
    [Abstract] [Full Text] [Related]

  • 20. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM, Tseng JT, Hong DY, Huang HS.
    Biochem J; 2011 Sep 01; 438(2):349-58. PubMed ID: 21649584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.